|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
2
|
Resverlogix Corp.
|
Jun 14, 2019 09:34AM
|
|
AEGIS-II trial
|
2
|
Resverlogix Corp.
|
Mar 22, 2018 10:09AM
|
|
Bioasis Announces Positive Results from a Microdialysis Study Showing Lead Investigational Candidate xB3 ™-001 Increased Brain Activity
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 25, 2018 04:41PM
|
|
Re: Resverlogix Supports Epigenetics Satellite Symposium and Provides Oral Presentation on Apabetalone at the European Society of Cardiology Congress 2018
|
2
|
Resverlogix Corp.
|
Aug 28, 2018 11:03AM
|
|
Re: AHA 2018
|
2
|
Resverlogix Corp.
|
Nov 12, 2018 08:48PM
|
|
Re: What if
|
2
|
Resverlogix Corp.
|
Mar 06, 2019 03:47PM
|
|
Re: Compounds and Autoimmune
|
2
|
Resverlogix Corp.
|
Jun 21, 2016 04:43PM
|
|
Re: TRIALS SITE/ SHOWS TWO APPROVED TRIALS
|
2
|
Zenith Epigenetics
|
Jun 16, 2016 12:27PM
|
|
Biotech Showcase January 8-10, 2018
|
2
|
Zenith Epigenetics
|
Dec 15, 2017 11:55AM
|
|
Re: New presentation
|
2
|
Resverlogix Corp.
|
Mar 21, 2017 11:50AM
|
|
Re: Rationale and Design of Apabetalone BETonMACE Trial
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 09:44AM
|
|
Re: Nasdaq!!
|
2
|
Resverlogix Corp.
|
Feb 05, 2019 04:02PM
|
|
Re: Delivery peptide conjugates of Trastuzumab
|
2
|
BIOASIS TECHNOLOGIES INC
|
Mar 20, 2018 03:40PM
|
|
Re: Resverlogix Announces Publication in High-impact, Peer-reviewed Journal, Clinical Epigenetics
|
2
|
Resverlogix Corp.
|
Nov 12, 2020 09:48AM
|
|
Re: Resverlogix Proudly Announces Funding for Phase 2 Trial Evaluating Apabetalone in PAH
|
2
|
Resverlogix Corp.
|
Mar 18, 2019 01:08PM
|
|
Re: system wide...
|
2
|
Resverlogix Corp.
|
Oct 29, 2017 02:55PM
|
|
biOasis Announces Nominees to the Board of Directors, Chairman Transition and Details of its Annual General Meeting of Shareholders
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 28, 2017 08:26AM
|
|
Re: Bioasis announces intention of a non- brokered PP
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 16, 2018 11:07AM
|
|
Re: BIO 2019 and Bioasis Tweets
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 01, 2019 02:21PM
|
|
Re: RVX - ESPR comparison....
|
2
|
Resverlogix Corp.
|
Aug 18, 2015 12:01PM
|
